Ibaraki, Japan

Kenichi Ikemoto

This inventor holds 1 USPTO granted patent. Top assignee: Nicca Chemical Co., Ltd.. Active years: 2006.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenichi Ikemoto: Innovator in Flame Retardant Technology

Introduction

Kenichi Ikemoto is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of flame retardant technology. His innovative work focuses on developing effective flame retardant treating agents and processes.

Latest Patents

Ikemoto holds a patent for "Flame retardant treating agents, flame retardant treating process and flame retardant treated fibers." This invention involves a phosphorus-based compound that enhances the flame retardant properties of polyester fiber woven fabrics. The process includes immersing the fabric in a treatment solution containing the flame retardant agent and applying heat to fix the agent to the fibers. This method ensures that the treated fibers maintain adequate cleaning durability while achieving sufficient flame retardant properties without the use of halogen-based compounds. He has 1 patent to his name.

Career Highlights

Kenichi Ikemoto is associated with Nicca Chemical Co., Ltd., where he continues to advance his research and development in flame retardant technologies. His work has been instrumental in creating safer materials for various applications.

Collaborations

Ikemoto collaborates with talented professionals in his field, including Hirotaka Kinoshita and Toru Makino. Their combined expertise contributes to the innovative solutions developed at Nicca Chemical Co., Ltd.

Conclusion

Kenichi Ikemoto's contributions to flame retardant technology highlight his commitment to innovation and safety in materials. His work not only advances the industry but also sets a standard for future developments in flame retardant treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…